Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

Langerhans cell histiocytosis specific to adulthood News | Kisho

Kisho

Not rare diseases news,
news about your rare disease.

Earlier

A case report highlights the successful surgical intervention for refractory adult-onset localized cutaneous Langerhans cell histiocytosis. This study contributes to the understanding of treatment options for this rare condition.

A recent case report highlights the use of contrast-enhanced sonography for diagnosing Langerhans cell hyperplasia in children with isolated liver involvement. This study contributes to the understanding of imaging techniques in rare pediatric liver diseases.

A Canadian multicenter case series investigates Langerhans cell histiocytosis in adults, providing new insights into its clinical presentation and management. This study contributes to the understanding of this rare disease, which may inform future research and treatment strategies.

A recent study highlights the complexities of diagnosing multifocal Langerhans cell histiocytosis, particularly when it involves the thyroid and multiple organs. This research underscores the need for heightened awareness and improved diagnostic strategies for this rare condition.

A case series published in PubMed highlights two patients with Nail Langerhans Cell Histiocytosis, showcasing both single-system and multisystem disease presentations. The study emphasizes the unique nail lesions associated with this rare condition.

A study published in PubMed highlights the use of clofarabine for treating relapsed or refractory Langerhans cell histiocytosis and non-LC histiocytosis. This research contributes to the understanding of treatment options for these rare diseases.

A case report details isolated esophageal Langerhans cell histiocytosis in an adult, contributing to the understanding of this rare condition. This case highlights the need for further research into the clinical implications and management of Langerhans cell histiocytosis.

Recent research highlights neurodegeneration as a significant aspect of Langerhans Cell Histiocytosis, suggesting it may not be merely a sequela. This finding could influence future therapeutic strategies and understanding of the disease.

A recent study highlights the multidisciplinary management approach for recurrent vulvar ulcers associated with Langerhans cell histiocytosis. This rare condition requires specialized care to address its complexities.

Not rare diseases news,news about your rare disease.